Back to results
US 8,409,132 B2Granted
Treatment indications informed by a priori implant information
AssigneeThe Invention Science Fund I, LLC
InventorsBran Ferren, Roderick A. Hyde, Muriel Y. Ishikawa, Eric C. Leuthardt, Dennis J. Rivet, Lowell L. Wood, Jr., Victoria Y. H. Wood
Life of this patent
Estimating the term…
Abstract
Systems and methods are described for implementing or deploying therapeutic administration systems for obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement.
Claims21
A therapeutic administration system comprising:
- one or more modules for obtaining a flow-change indicative measurement;
- one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;
- a first dispenser operable for dispensing at least a lytic material;
- a second dispenser operable for targeting an implant site;
- and
- a wireless-communication device operable for communicating a selection of the first dispenser or the second dispenser.
3 more elements
A therapeutic administration system comprising:
- one or more modules for obtaining a flow-change-indicative measurement;
- one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;
- a first dispenser operable for dispensing at least a clot-reducing agent;
- a second dispenser operable for targeting an implant site;
- and
- a wireless-communication device operable for communicating a selection of the first dispenser or the second dispenser.
3 more elements
A therapeutic administration method comprising:
- obtaining a flow-change-indicative measurement;
- signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;
- dispensing, from a first dispenser, at least a lytic material;
- targeting, utilizing a second dispenser, an implant site and
- communicating, using a wireless-communication device, a selection of the first dispenser or the second dispenser.
2 more elements
Dependencies are inferred from the claim text.